Literature DB >> 27478954

Atypical inflammatory demyelinating syndromes of the CNS.

Todd A Hardy1, Stephen W Reddel2, Michael H Barnett3, Jacqueline Palace4, Claudia F Lucchinetti5, Brian G Weinshenker5.   

Abstract

Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27478954     DOI: 10.1016/S1474-4422(16)30043-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  31 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

Review 2.  [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].

Authors:  O Aktas; M P Wattjes; M Stangel; H-P Hartung
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

3.  Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States.

Authors:  Mahboubeh Fereidan-Esfahani; Paul A Decker; Jeanette E Eckel Passow; Claudia F Lucchinetti; Eoin Patrick Flanagan; William Oliver Tobin
Journal:  Eur J Neurol       Date:  2021-12-09       Impact factor: 6.089

Review 4.  Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept.

Authors:  Romana Höftberger; Hans Lassmann; Thomas Berger; Markus Reindl
Journal:  Nat Rev Neurol       Date:  2022-08-15       Impact factor: 44.711

5.  Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity?

Authors:  Zélia Poullet; Julie Pique; Adil Maarouf; Clemence Boutiere; Audrey Rico; Sarah Demortiere; Pierre Durozard; Caroline Papeix; Elisabeth Maillart; Nicolas Collongues; Xavier Ayrignac; Helene Zephir; Romain Deschamps; Jonathan Ciron; Jean Pelletier; Romain Marignier; Bertrand Audoin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-04-26

6.  Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.

Authors:  Sharon A Sagan; Ryan C Winger; Andrés Cruz-Herranz; Patricia A Nelson; Sarah Hagberg; Corey N Miller; Collin M Spencer; Peggy P Ho; Jeffrey L Bennett; Michael Levy; Marc H Levin; Alan S Verkman; Lawrence Steinman; Ari J Green; Mark S Anderson; Raymond A Sobel; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

7.  Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies.

Authors:  Christoph Metze; Alexander Winkelmann; Micha Loebermann; Michael Hecker; Brunhilde Schweiger; Emil Christian Reisinger; Uwe Klaus Zettl
Journal:  CNS Neurosci Ther       Date:  2018-07-25       Impact factor: 5.243

Review 8.  Myelin oligodendrocyte glycoprotein antibodies in neurological disease.

Authors:  Markus Reindl; Patrick Waters
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

9.  Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis.

Authors:  Evan A Jolliffe; Yong Guo; Todd A Hardy; P Pearse Morris; Eoin P Flanagan; Claudia F Lucchinetti; W Oliver Tobin
Journal:  Neurology       Date:  2021-05-19       Impact factor: 11.800

10.  Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Maria-Eleptheria Evangelopoulos; Theodore Argyrakos; John S Tzartos; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Georgios Velonakis; Panagiotis Toulas; Elias Gialafos; Antonios Dimitrakopoulos; Erasmia Psimenou; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Ther Adv Neurol Disord       Date:  2021-05-18       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.